Centre issues Model Rules to States to aid Ease of Doing Business in Agroforestry (See 'Corp Brief') We have to make cycling trend in this modern generation: Mandaviya (See 'Corp Brief') Sonowal hails Brahma Kumaris for 50 years of spiritual service and human upliftment (See 'Corp Brief') CEA organises All-India Electrical Safety awareness programme (See 'Corp Brief') Arbitration & Conciliation Act - Commercial Court not justified in refusing to release 25% of arbitral award to petitioner-company solely due to its change of name: HC (See 'Legal Desk') SEBI - Delay in filing appeal not condonable where facts reflect that appellant was clearly aware of proceedings commenced by SEBI but did not prosecute appeal: SAT (See 'Legal Desk') India sends 1st consignment of rose-scented Litchi from Pathankot to Qatar (See 'Corp Brief') Govt approves ESI Amnesty Scheme - 2025 to reduce litigation (See 'Corp Brief') Sonowal inaugurates India's First Maritime NBFC - Sagarmala Finance Corporation Limited (See 'Corp Brief') NeGD launches 'AI in Governance' Training Program for Govt Officials at IIT Delhi (See 'Corp Brief') ECI starts proceedings to delist 345 RUPPs to begin with (See 'Corp Brief') Negotiable Instruments Act - as is trite law, a legal notice must be read as a whole & isolated errors such as typographical mistakes should not invalidate the entire notice: HC (See 'Legal Desk') Mega Infra Projects in Jharkhand, Sikkim, Assam & Arunachal Pradesh reviewed (See 'Corp Brief') President of India to preside over 'MSME Day' (See 'Corp Brief') NMDC invites applications for fully sponsored Education Programs for Tribal Youth (See 'Corp Brief') PMLA - Attachment of property does not effect or transfer title, unless property is confiscated and it can be when accused is convicted: SAFEMA (See 'Legal Desk') Workshop with FinTech Companies on expanding FASTag ecosystem (See 'Corp Brief') Bid submission timeline extended for SECI's Green Ammonia tender (See 'Corp Brief') Axiom-4 Marks Realisation of Vikram Sarabhai's dream: MoS (See 'Corp Brief') IBC - Dues of State is entitled to be treated as secured creditor u/s 53 of IBC: NCLAT (See 'Legal Desk') ECI to begin Special Intensive Revision of Electoral Rolls in Bihar (See 'Corp Brief') MoS calls for closer collaboration among IITs, IIMs, AIIMS, IIMC & CSIR (See 'Corp Brief') 7th Helicopter & Small Aircraft Summit held in Pune (See 'Corp Brief') CCI approves acquisition of shares in Aakash Educational by Manipal Health Systems (See 'Corp Brief') IPR - Merely adding mandarin character can't add any distinctiveness for being granted registration, and that too qua pharmaceutical product, if said character can't be deciphered by general public: HC (See 'Legal Desk') CCI approves acquisition in Manappuram Finance & Manappuram Asset Finance by Bain Capital (See 'Corp Brief') CCI okays acquisition of equity of Haldiram Snacks by Alpha Wave Ventures (See 'Corp Brief') Amended BharatNet Program operationalises in Gujarat (See 'Corp Brief') PMLA - Enforcement Directorate must pass orders under of retention under section 20(1) and 21(1) of the PMLA in respect of seized property and seized records: SAFEMA (See 'Legal Desk') Sonowal calls for Sports Resurgence in Assam (See 'Corp Brief') Vanijya Bhawan is symbol of Good Governance, Excellence: Goyal (See 'Corp Brief') SARFAESI - equitable considerations cannot override statutory auction process; writ jurisdiction under Article 226 cannot be invoked to compel bank to accept One Time Settlement or interfere with SARFAESI proceedings already adjudicated under statutory forum: HC (See 'Legal Desk') Hindustan Copper welcomes Chile's CODELCO Team to India (See 'Corp Brief') IICA inks MoU with National Academy of Defence Production (See 'Corp Brief') Competition Act - mere dissatisfaction with service conditions or operational practices did not warrant intervention, more so where any prima facie case under Section 3 or 4 of the Act are not made out: CCI (See 'Legal Desk') Chouhan reviews ICAR-Central Institute of Agricultural Engineering in Bhopal (See 'Corp Brief') DG RPF calls for synergised action by RPF-GRP across States to Safeguard Railway Pax (See 'Corp Brief') Trade Marks - Where an application for registration of Trade Mark is filed on proposed to be used basis, the mark can still acquire distinctiveness before registration; refusal of registration based on lack of distinctiveness unjustified, more so where similar marks were registered by same authority: HC (See 'Legal Desk') PM leads nationwide celebrations of 11th International Day of Yoga (See 'Corp Brief') PMLA - Once property is already auctioned by bank under SARFAESI, legal implications of sale depended on whether sale certificate had been issued: SAFEMA (See 'Legal Desk') NCLAT is not a mere rubber stamp for CoC decisions (See CORP EINSICHT)

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.